CP-339818

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCP-339818
Drug Alias NameCP-393223CP-339818CP-394322CP-393224
ClassificationSmall molecules
Mechanisms of ActionPotassium channel blockers
TargetsPotassium channel
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A